Publications by authors named "Luis F Gonzalez-Mosquera"
Article Synopsis
- The study investigates how involvement of multiple organ systems in COVID-19 patients relates to in-hospital mortality and length of stay in the hospital.
- Data from 808 patients at a New York hospital revealed that the more organ systems affected, the higher the risk of death and longer hospital stays.
- Findings also indicate that certain lab values, like platelet and white blood cell counts, are significant indicators of mortality risk, highlighting the potential for these metrics to guide treatment decisions.
There are few reported cases of ALK gene rearranged (ALK+) non-small cell lung cancer (NSCLC) during pregnancy. There is a lack of information on the safety of ALK inhibitors in pregnant patients. We present a 25-year-old African American woman who was diagnosed with metastatic ALK+ lung adenocarcinoma at 15 weeks of gestation.
View Article and Find Full Text PDFWe analyzed the National Inpatient Sample (NIS) database to study the sepsis-related outcomes in patients with Philadelphia negative myeloproliferative neoplasms (MPN). A total of 82,087 patients were included, most had essential thrombocytosis (83.7%), followed by polycythemia vera (13.
View Article and Find Full Text PDFWe analyzed the National Inpatient Sample (NIS) database to study the sepsis-related outcomes in patients with Philadelphia negative myeloproliferative neoplasms (MPN). A total of 82,087 patients were included, most had essential thrombocytosis (83.7%), followed by polycythemia vera (13.
View Article and Find Full Text PDFIntroduction: COVID-19 affects the hematologic system. This article evaluated the impact of hematologic involvement of different blood cell line parameters of white blood cells including absolute neutrophil count (ANC), hemoglobin, and platelets in COVID-19 patients and their association with hospital mortality and length of stay (LOS).
Methods: This was a retrospective study of 475 patients with confirmed positive COVID-19 infection and hematologic abnormalities in the metropolitan New York City area.